| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 环(甘氨酸-L-脯氨酸)二肽; Cyclo(Gly-L-Pro) | CFN96160 | 3705-27-9 | C7H10N2O2 = 154.2 | 10mg | QQ客服：3257982914 |
| L-苯丙氨酸; L-Phenylalanine | CFN93152 | 63-91-2 | C9H11NO2 = 165.19 | 20mg | QQ客服：1457312923 |
| 氧化表小檗碱; Oxyepiberberine | CFN90758 | 19716-60-0 | C20H17NO5 = 351.4 | 5mg | QQ客服：2159513211 |
| L-肌肽; L-carnosine | CFN93091 | 305-84-0 | C9H14N4O3 = 226.23 | 20mg | QQ客服：2056216494 |
| 斯佩加春; Spegatrine | CFN96170 | 47326-53-4 | C20H25N2O2 = 325.4 | 10mg | QQ客服：2056216494 |
| 3-Hydroxy-3-acetonyloxindole; 3-Hydroxy-3-acetonyloxindole | CFN96171 | 33417-17-3 | C11H11NO3 = 205.2 | 5mg | QQ客服：2056216494 |
| Crassanine; Crassanine | CFN96176 | 16790-92-4 | C23H30N2O5 = 414.5 | 5mg | QQ客服：1457312923 |
| 佩立任碱; Pelirine | CFN96181 | 30435-26-8 | C21H26N2O3 = 354.5 | 5mg | QQ客服：2056216494 |
| 1-肉桂酰吡咯烷; 1-Cinnamoylpyrrolidine | CFN96190 | 52438-21-8 | C13H15NO = 201.3 | 5mg | QQ客服：215959384 |
| 2-(1H-Indole-3-carboxamido)benzoic acid; 2-(1H-Indole-3-carboxamido)benzoic acid | CFN96192 | 171817-95-1 | C16H12N2O3 = 280.3 | 5mg | QQ客服：2159513211 |
| 马兜铃酸D; Aristolochic acid D | CFN90783 | 17413-38-6 | C17H11NO8 = 357.3 | 10mg | QQ客服：3257982914 |
| 硫酸长春质碱; Catharanthine Sulfate | CFN93298 | 70674-90-7 | C21H26N2O6S = 434.51 | 5mg | QQ客服：1457312923 |
| 蒜氨酸; 蒜碱; Alliin | CFN93533 | 556-27-4 | C6H11NO3S = 177.22 | 5mg | QQ客服：2056216494 |
| 澳洲边茄碱; Solamarine | CFN93102 | 20318-30-3 | C45H73NO16 = 884.1 | 5mg | QQ客服：2056216494 |
| 碘化木兰花碱; Magnoflorine Iodide | CFN90797 | 4277-43-4 | C20H24NO4.I = 469.31 | 20mg | QQ客服：3257982914 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)